Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04744545 · ClinicalTrials.gov registry record · NA
RCT of Adjunctive Curcumin and the Meru Health Program
A NA study, sponsored by Meru Health.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04744545: Completed NA study, sponsored by Meru Health.
NCT04744545 is a NA study that has completed, run by Meru Health. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04744545, a NA study, has completed, sponsored by Meru Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a randomized controlled trial (RCT) to compare the Meru Health Program plus adjunctive curcumin (MHP-CUR) versus Meru Health Program only (MHP-ONLY) for adults with depression. Meru Health is a 12-week integrative treatment program based on several evidence-based practices and overseen by licensed clinical therapists that is delivered via a Smartphone app. The primary objective of the study is to determine the feasibility, initial efficacy (depressive symptoms), and potential harms of taking adjunctive curcumin supplementation during the 12-week MHP among adults with depression. Secondary objectives include comparing changes in inflammation biomarkers, anxiety, worker productivity, and burnout that occur during the program between those in MHP-CUR and MHP-ONLY.
Interventions
- DIETARY_SUPPLEMENT Curcumin
- BEHAVIORAL Meru Health Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2021-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04744545
The ClinicalTrials.gov registry entry for NCT04744545 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Meru Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Curcumin is the first listed.
NCT04744545 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04744545 about?
NCT04744545 is a clinical study titled "RCT of Adjunctive Curcumin and the Meru Health Program". This is a randomized controlled trial (RCT) to compare the Meru Health Program plus adjunctive curcumin (MHP-CUR) versus Meru Health Program only (MHP-ONLY) for adults with depression. Meru Health is a 12-week integrative treatment program based on several evidence-based practices and overseen by li...
What is the current status of trial NCT04744545?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-02-01. Estimated completion is 2021-12-30.
What interventions are being tested in trial NCT04744545?
The interventions under investigation include: Curcumin (DIETARY_SUPPLEMENT), Meru Health Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04744545?
This trial is sponsored by Meru Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.